P-169Apatinib as non-first-line treatment in patients with advanced cholangiocarcinoma. (2nd July 2019) - Lin, J; Yang, X; Mao, J; Yang, X; Wang, D; Zhang, L; Bai, Y; Bian, J; Long, J; Xie, F; Huang, H; Sang, X; et al.